Healthcare Industry News: retractor
News Release - January 19, 2010
Integra LifeSciences Awarded Contract With HealthTrust Purchasing Group to Provide Luxtec(R) Surgical Illumination ProductsPLAINSBORO, N.J., Jan. 19, 2010 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) announced today that its subsidiary, Integra Luxtec, Inc., has signed a three-year contract with HealthTrust Purchasing Group to provide Luxtec(R) surgical headlights, light sources and accessories to its members. Under this agreement, HealthTrust members will have access to a wide variety of products, including the Luxtec(R) UltraLite(R) Pro headlight, one of the most comfortable surgical headlights on the market, and the Luxtec(R) MLX 300W xenon light source, which provides a 1,000 hour lamp warranty.
"We are very excited that HealthTrust has selected Integra as a contracted supplier of surgical headlights, lightsources and fiber optic cables," said Debbie Leonetti, President, Integra Surgical. "This is our first contract with HealthTrust for this product category and reflects our commitment to provide its members with Integra's highest quality products and service."
Integra is one of the world's largest suppliers of surgical vision systems. Most surgical procedures require directed white light to visualize blood vessels, muscle tissue and specific anatomical features. Over 60,000 surgeons worldwide use Luxtec(R) light sources for optimal surgical site visualization.
Integra Surgical's direct sales organization and distributor network sells Luxtec(R) products. Integra Surgical is a leading provider of surgical instruments used in general surgery, neurosurgery, cardiac surgery and most other surgical specialties. Brands associated with Integra Surgical include Jarit(R), Ruggles(TM)-Redmond(TM), the Omni-Tract(R) family of retractor systems, and the Luxtec(R) illumination products. For more information, visit www.integrasurgical.com.
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Integra's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.integra-ls.com.
About HealthTrust Purchasing Group
HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports nearly 1,400 not-for-profit and for-profit acute care facilities, as well as ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $15 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027. Their website is www.healthtrustpg.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra LifeSciences. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Luxtec(R), Jarit(R), Ruggles(TM)-Redmond(TM), and Omni-Tract(R) may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
Source: Integra LifeSciences
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.